Study: Pfizer vaccine 94 percent effective in 1 million and 200 thousand people

The first major study of the coronary vaccine from Pfizer/ B The independent ONTech has confirmed the promised results in testing. A study by 1.2 million people in Israel ʹ has vaccinated most of its citizens with Pfizer vaccines over the past two months found that the two doses [...]
Research by 1.2 million people in Israel ʹthe country that has vaccinated most of its citizens with Pfizer vaccines over the past two months found that the two doses had reduced symptoms to 94% in all age groupswrites Guardian, translates Periscope.
This research is nationwide and suggests that the vaccine is effective for all of the coddy-19s, a consistent find with what was done in testing,” said in publication.
The study has not shed light on how vaccines operate against the version of South Africa, which has caused anxiety recently. /Periscope











